Actavis, Warner Chilcott meet last regulatory requirements for merger

DUBLIN — Ireland's High Court has approved Actavis' acquisition of Warner Chilcott, the drug makers said.

The companies said the approval of Irish authorities meant that they had obtained all regulatory approvals required to complete the transaction, and that it now remained subject to satisfaction of other customary closing conditions and would occur as soon as practicable.

Actavis and Warner Chilcott announced the $8.5 billion merger deal in May. The companies' shareholders voted to approve it on Sept. 10.